Name: Parkinson’s Disease and Psychosis Awareness – “The Importance of How Updated CMS Psychotropic Guidelines May Impact Treatment”
Start: 2025-04-30T14:00:00-04:00
End: 2025-04-30T15:00:00-04:00

Join us for a webinar on Apr 30, 2025 at 2:00 PM EDT.

Discover how the latest updates to CMS Psychotropic Guidelines can influence treatment approaches. Join PharmScript, LLC. for an insightful webinar hosted by Matt Jaco, PharmD, from Acadia Pharmaceuticals. Tune in to review these impactful changes.

Matt will share the following learning objectives:

1) Understand Parkinson’s Disease (PD) and PD psychosis.
2) Review appropriate management of hallucinations and delusions associated with PD psychosis.
3) Review efficacy and safety data for Nuplazid.
4) Review upcoming CMS regulatory changes related to psychotropic medication and responsibilities of a medical director.

This webinar is for informational purposes only.

Parkinson’s Disease and Psychosis Awareness – “The Importance of How Updated CMS Psychotropic Guidelines May Impact Treatment”

April 30 @ 2:00 pm - 3:00 pm

Event Navigation

Parkinson’s Disease and Psychosis Awareness – “The Importance of How Updated CMS Psychotropic Guidelines May Impact Treatment”

April 30 @ 2:00 pm - 3:00 pm

Share This Story, Choose Your Platform!

Event Navigation